Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β-induced cytotoxicity and reduces nitric oxide production

Journal of Clinical Investigation

Volumn 101, Issue 9, 1998, Pages 1811-1820

  Hohmeier, Hans Ewald ^a   Thigpen, Anice ^c   Tran, Veronique Vien ^a,b   Davis, Richard ^c   Newgard, Christopher B ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c BetaGene Inc   (United States)

Author keywords

Cytokines; Immunoprotection; Insulin dependent diabetes mellitus; Islet cells; Molecular engineering

Indexed keywords

INTERLEUKIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CYTOTOXICITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0032080663     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1489     Document Type: Article

References (63)

1. Mandrup-Poulsen, T. 1996. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia. 39:1005-1029.
2. Rabinovitch, A. 1993. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev. 1:215-240.
3. Corbett, J.A., and M.L. McDaniel. 1992. Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes. 41:897-903.
4. Eizirik, D.L., M. Flodstrom, A.E. Karlsen, and N. Welsh. 1996. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia. 39:875-890.
5. Halban, P.A., G.A. Praz, and C.B. Wollheim. 1983. Abnormal glucose metabolism accompanies failure of glucose to stimulate insulin release from a pancreatic islet cell line (RINm5F). Biochem. J. 212:439-443.
6. Newgard, C.B., S. Clark, H. BeltrandelRio, H.E. Hohmeier, C. Quaade, and K. Normington. 1997. Engineered cell lines for insulin replacement in diabetes: current status and future prospects. Diabetologia. 40:S42-S47.
7. Mandrup-Poulsen, T., G.A. Spinas, S.J. Prowse, B.S. Hansen, D.W. Jorgensen, K. Bendtzen, J.H. Nielsen, and J. Nerup. 1987. Islet cytotoxicity of interleukin-1. Influence of culture conditions and islet donor characteristics. Diabetes. 36:641-647.
8. Malaisse, W.J., F. Malaisse-Lagae, A. Sener, and D.G. Pipeleers. 1982. Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc. Natl. Acad. Sci. USA. 79:927-930.
9. Asayama, K., N.W. Kooy, and I.M. Burr. 1986. Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J. Lab. Clin. Med. 107:459-464.
10. Lenzen, S., J. Drinkgern, and M. Tiedge. 1995. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biol. Med. 20:463-166.
11. Sumoski, W., H. Baquerizo, and A. Rabinovitch. 1989. Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia. 32:792-796.
12. Burkart, V., and H. Kolb. 1993. Protection of islet cells from inflammatory cell death in vitro. Clin. Exp. Immunol. 93:273-278.
13. Yamada, K., C. Inada, S. Otabe, N. Takane, H. Hayashi, and K. Nonaka. 1993. Effects of free radical scavengers on cytokine actions on islet cells. Acta Endocrinol. 128:379-384.
14. Bannister, J.V., W.H. Bannister, and G. Rotilio. 1987. Aspects of the structure, function and applications of superoxide dismutase. Crit. Rev. Biochem. 22:111-180.
15. Hassan, H.M. 1988. Biosynthesis and regulation of superoxide dismutases. Free Radical Biol. Med. 5:377-385.
16. Touati, D. 1988. Molecular genetics of superoxide dismutases. Free Radical Biol. Med. 5:393-402.
17. Wong, G.H.W., and D.V. Goeddel. 1988. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science. 242:941-944.
18. Masuda, A., D.L. Longo, Y. Kobayashi, E. Appella, J. Oppenheim, and K. Matsushima. 1988. Induction of mitochondrial manganese superoxide dismutase by interleukin 1. FASEB (Fed. Am. Soc. Exp. Biol.) J. 2:3087-3091.
19. Wong, G.H.W., J.H. Elwell, L.W. Oberley, and D.V. Goeddel. 1989. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:923-931.
20. Hakan Borg, L.A., E. Cagliero, S. Sandler, N. Welsh, and D.L. Eizirik. 1992. Interleukin-1β increases the activity of superoxide dismutase in rat pancreatic islets. Endocrinology. 130:2851-2857.
21. Southern, C., D. Schulster, and I.C. Green. 1990. Inhibition of insulin secretion by interleukin-1β and tumor necrosis factor-α via an L-arginine-dependent nitric oxide generation mechanism. FEBS Lett. 276:42-44.
22. Corbett, J.A., and M.L. McDaniel. 1994. Reversibility of interleukin-1β-induced islet destruction and dysfunction by the inhhibition of nitric oxide synthase. Biochem. J. 299:719-724.
23. Delaney, C.A., B. Tyrberg, L. Bouwens, H. Vaghef, B. Hellman, and D.L. Eizirik. 1996. Sensitivity of human pancreatic islets to peroxynitirite-induced cell dysfunction and death. FEBS Lett. 394:300-306.
24. Clark, S.A., B.L. Burnham, and W. Chick. 1990. Modulation of glucose-induced insulin secretion from a rat clonal beta-cell line. Endocrinology. 1227: 2779-2788.
25. Clark, S., C. Quaade, H. Constandy, P. Hansen, P. Halban, S. Ferber, C.B. Newgard, and K. Normington. 1997. Novel insulinoma cell lines produced by iterative engineering of GLUT-2, glucokinase and human insulin expression. Diabetes. 46:958-967.
26. Hohmeier, H.E., H. BeltrandelRio, S.A. Clark, R. Henkel-Reiger, K. Normington, and C.B. Newgard. 1997. Regulation of insulin secretion from novel engineered insulinoma cell lines. Diabetes. 46:968-977.
27. Asfari, M., D. Janjic, P. Meda, G. Li, P.A. Halban, and C.B. Wollheim. 1991. Establishment of 2-mercaptoethanol dependent differentiated insulin-secreting cell lines. Endocrinology. 130:167-178.
28. Noel, R.J., P.A. Antinozzi, J.D. McGarry, and C.B. Newgard. 1997. Engineering of glycerol-stimulated insulin secretion in islet beta cells: differential metabolic fates of glucose and glycerol provide insight into mechanisms of stimulus-secretion coupling. J. Biol. Chem. 272:18621-18627.
29. Oberley, T.D., L.W. Oberley, A.L. Slattery, L.J. Lauchner, and J.H. Elwell. 1990. Immunohistochemical localization of antioxidant enzymes in adult Syrian hamster tissues and during kidney development. Am. J. Pathol. 137:199-214.
30. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55-63.
31. Schnedl, W.J., S. Ferber, J.H. Johnson, and C.B. Newgard. 1994. Streptozotocin transport and cytotoxicity: specific enhancement in GLUT-2 expressing cells. Diabetes. 43:1326-1333.
32. Fiennes, A.G.T.W., J. Walton, D. Winterbourne, D. McGlashan, and J. Herman-Taylor. 1987. Quantitative correlation of neutral red dye uptake with cell number in human cancer cell cultures. Cell Biol. Int. 11:373-378.
33. Hart, R., C. Liu, A.M. Shadiack, R.J. McCormack, and G.M. Jonakait. 1993. An mRNA homologous to interleukin-1 receptor type 1 is expressed in cultured rat sympathetic ganglia. J. Neuroimmunol. 44:49-56.
34. Puga, A., and E. Oates. 1987. Isolation and nucleotide sequence of rat Cu/Zn superoxide dismutase cDNA clones. Free Radical Res. Commun. 3:337-349.
35. Karlsen, A.E., H. Andersen, H. Vissing, M. Larsen, S.J. Fey B.G. Cuartero, O. Madsen, J.S. Petersen, S.B. Nortensen, T. Mandrup-Poulsen, E. Boel, and J. Nerup. 1995. Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes. 44:753-758.
36. Danielson, P.E., S. Forss-Petter, M.A.D. Brow, L. Clavettal, J. Douglass, R.J. Milner, and J.G. Sutcliffe. 1988. A cDNA clone of the rat mRNA encoding cyclophilin. DNA. 7:261-267.
37. Bailey, J.M., and N. Davidson. 1976. Methylmercury as a reversible denaturing agent for agarose gel electrophoresis. Anal. Biochem. 70:75-85.
38. Ho, Y.S., and J.D. Crapo. 1987. Nucleotide sequences of cDNAs coding for rat manganese-containing superoxide dismutase. Nucleic Acids Res. 15: 10070.
39. Marklund, S.L. 1985. Pyrogallol autoxidation. In CRC Handbook of Methods for Oxygen Radical Research. R. Greenwald, editor. CRC Press, Boca Raton, FL. 243-247.
40. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
41. 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
42. Coligan, J.E., A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober. 1992. Current Protocols in Immunology. Greene Publishing and Wiley-Interscience, New York. Vol. 2:7.1-7.10.
43. Ferber, S., H. BeltrandelRio, J.H. Johnson, R.J. Noel, L.E. Cassidy, S. Clark, T.C. Becker, S.D. Hughes, and C.B. Newgard. 1994. GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release. Relationship to glucokinase activity. J. Biol. Chem. 269:11523-11529.
44. Olivares, I.P., L. Bucio, V. Souza, A. Carabez, and M.C. Gutierrez-Ruiz. 1997. Comparative study of the damage produced by acute ethanol and acetaldehyde treatment in a human fetal hepatic cell lines. Toxicology. 120:133-144.
45. Hardwick, S.J., L. Hegyi, K. Clare, N.S. Law, K.L. Carpenter, M.J. Mitchinson, and J.N. Skepper. 1996. Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein. J. Pathology. 179:294-302.
46. Becker, T., H. BeltrandelRio, R.J. Noel, J.H. Johnson, and C.B. Newgard. 1994. Overexpression of hexo kinase I in isolated islets of langerhans via recombinant adenovirus: enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. J. Biol. Chem. 269:21234-21238.
47. Bendtzen, K. 1988. Interleukin 1, interleukin 6, and tumor necrosis factor in infection, inflammation, and immunity. Immunol. Lett. 19:183-192.
48. Andersson, U., J. Andersson, A. Lindfors, K. Wagner, G. Moller, and C.H. Heusser. 1990. Simultaneous production of interleukin 2, interleukin 4, and interferon-gamma by activated human blood lymphocytes. Eur. J. Immunol. 20:1591-1596.
49. Castano, L., and G.S. Eisenbarth. 1994. Type I diabetes: a chronic autoimmune disease of human, mouse and rat. Ann. Rev. Immunol. 8:647-679.
50. Rossini, A.A., E.S. Handler, D.L. Greiner, and J.P. Mordes. 1991. Insulin dependent diabetes mellitus hypothesis of autoimmunity. Autoimmunity. 8: 221-235.
51. Efrat, S., and N. Fleischer. 1996. Engineering the pancreatic β-cell. In Diabetes Mellitus: a Fundamental and Clincial Text. D. LeRoith, S.I. Taylor, and J.M. Olefsky, editors. Lippincott-Raven, New York. 438-442.
52. Kessler, L., C. Jesser, Y. Lombard, V. Karsten, A. Belcourt, M. Pinget, and P. Poindron. 1996. Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: in vivo and in vitro studies. J. Leukocyte Biol. 60:729-736.
53. Janjic, D., and M. Asfari. 1992. Effects of cytokines on rat insulinoma INS-1 cells. J. Endocrinol. 132:67-76.
54. Meredith, M., M.E. Rabaglia, J.A. Corbett, and S.A. Metz. 1996. Dual functional effects of interleukin-1β on purine nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes. 45:1783-1791.
55. Sen, C.K., and L. Packer. 1996. Antioxidant and redox regulation of gene transcription. FASEB (Fed. Am. Soc. Exp. Biol.) J. 10:709-720.
56. Lander, H. 1997. An essential role for free radicals and derived species in signal transduction. FASEB (Fed. Am. Soc. Exp. Biol.) J. 11:118-124.
57. Kwon, G., J.A. Corbett, C.P. Rodi, P.M. Sullivan, and M.L. McDaniel. 1995. IL-1β induces the expression of nitric oxide synthase in rats islets and RINm5F cells: evidence for the involvement of NFκB in the signaling mechanism. Endocrinology. 136:4790-4795.
58. Abate, C., L. Patel, F.J. Rauscher, III, and T. Curran. 1990. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science. 249:1157-1161.
59. Ankarcrona, M., J.M. Dypbukt, B. Brune, and P. Nicotera. 1994. Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINmSF cells. Exp. Cell Res. 213:172-177.
60. Kaneto, H., J. Fujii, H.G. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada, and N. Taniguchi. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes. 44:733-738.
61. Suarez-Pinzon, W.L., K. Strynadka, R. Schulz, and A. Rabinovitch. 1994. Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology. 134:1006-1010.
62. Rabinovitch, A., W.L. Suarez-Pinzon, Y. Shi, A.R. Morgan, and R.C. Bleackley. 1994. DNA fragmentation is an early event in cytokine-induced islet beta cell destruction. Diabetologia. 37:733-738.
63. Heitmeier, M.R., A.L. Scarim, and J.A. Corbett. 1997. Interferon-γ increases the sensitivity of islets of Langerhans for inducible nitric oxide synthase expression induced by interleukin 1. J. Biol. Chem. 272:13697-13704.